The Adiana permanent contraception system supported by UK's NICE

Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the United Kingdom's National Institute for Health and Clinical Excellence (NICE), in its updated guidance for hysteroscopic sterilization, supports the use of Hologic's Adiana((R)) permanent contraception system. NICE, a part of the National Health Service (NHS), is an independent organization responsible for providing national guidance on treatments and care for those using the NHS in the United Kingdom. The Adiana system received CE marking approval in January 2009 and U.S. Food and Drug Administration (FDA) approval in July 2009. The Adiana system is designed to provide women a minimally-invasive, non-incision alternative to traditional, surgical means of permanent contraception.

The updated guidance concludes that the data on the safety and efficacy of hysteroscopic sterilization by tubal cannulation and placement of intrafallopian implants supports the use of the Adiana procedure in the U.K.

"This is an important milestone for Hologic and our GYN surgical products business in the U.K.," said Tony Kingsley, senior vice president, GYN surgical products at Hologic. "With more than 50 NHS surgeons now trained to perform the Adiana procedure, the updated NICE guidance should further support our efforts to establish Hologic's minimally-invasive, safe and effective Adiana system in the U.K."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Advantech partners with Imprivata® to validate medical tablets and PCs for increased data security in healthcare